Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: A sex difference analysis.

[1]  K. Tanabe,et al.  Trends Over Time in the Incidences of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction During the Past Decade in a Rural Japanese High-Aged Population. , 2021, Circulation journal : official journal of the Japanese Circulation Society.

[2]  Ji-hoon Jung,et al.  Gender differences in clinical outcomes of acute myocardial infarction undergoing percutaneous coronary intervention: insights from the KAMIR-NIH Registry , 2020, Journal of geriatric cardiology : JGC.

[3]  M. Toyofuku,et al.  Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-2. , 2020, Circulation Journal.

[4]  P. Heidenreich,et al.  Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention. , 2020, Journal of cardiology.

[5]  H. Schunkert,et al.  Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes , 2020, Annals of Internal Medicine.

[6]  P. Armstrong,et al.  Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI. , 2020, Journal of the American College of Cardiology.

[7]  Samin K. Sharma,et al.  Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. , 2020, Journal of the American College of Cardiology.

[8]  S. Kohsaka,et al.  Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia , 2020, Journal of clinical medicine.

[9]  S. Kohsaka,et al.  Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry , 2020, Cardiovascular Intervention and Therapeutics.

[10]  F. Otsuka,et al.  JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. , 2020, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Qingbo Xu,et al.  Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. , 2020, Journal of the American College of Cardiology.

[12]  K. Tanabe,et al.  Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective , 2019, Cardiovascular Intervention and Therapeutics.

[13]  T. Kitazono,et al.  Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)　- 1-Year Follow-up Results of a Postmarketing Observational Study. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[14]  M. Toyofuku,et al.  Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention. , 2019, Circulation. Cardiovascular interventions.

[15]  H. Bueno,et al.  Worse 12-month prognosis in women with non-valvular atrial fibrillation undergoing percutaneous coronary intervention. , 2019, Thrombosis research.

[16]  M. Price,et al.  Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention , 2019, Circulation.

[17]  D. Cohen,et al.  Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention , 2019, Thrombosis and Haemostasis.

[18]  H. Suryapranata,et al.  Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation. , 2019, Journal of cardiology.

[19]  T. Akasaka,et al.  Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J‐PCI Registry) , 2019, Journal of the American Heart Association.

[20]  S. Yasuda,et al.  Current Status of Cardiovascular Medicine in the Aging Society of Japan. , 2018, Circulation.

[21]  M. Gulati,et al.  Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: Insights from 6.6 million PCI procedures in the United States , 2018, PloS one.

[22]  F. Gaita,et al.  Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. , 2018, Thrombosis research.

[23]  T. Akasaka,et al.  Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores , 2018, Journal of the American Heart Association.

[24]  B. Gersh,et al.  Sex Differences in Long-Term Cause-Specific Mortality After Percutaneous Coronary Intervention: Temporal Trends and Mechanisms , 2018, Circulation. Cardiovascular interventions.

[25]  Jing-jing Xu,et al.  Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non‐ST‐elevation myocardial infarction vs ST‐elevation myocardial infarction) on 2‐year outcomes in patients undergoing percutaneous coronary intervention , 2018, Journal of interventional cardiology.

[26]  Mario J. Garcia,et al.  Contemporary Sex-Based Differences by Age in Presenting Characteristics, Use of an Early Invasive Strategy, and Inhospital Mortality in Patients With Non–ST-Segment–Elevation Myocardial Infarction in the United States , 2018, Circulation. Cardiovascular interventions.

[27]  H. Miyata,et al.  Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long‐Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry , 2017, Journal of the American Heart Association.

[28]  Deepak L. Bhatt,et al.  Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting. , 2017, Journal of the American College of Cardiology.

[29]  Deepak L. Bhatt,et al.  Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials , 2017, The Lancet.

[30]  C. Held,et al.  Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial , 2016, European heart journal.

[31]  Tracy Y. Wang,et al.  A review of sex-specific benefits and risks of antithrombotic therapy in acute coronary syndrome , 2016, European heart journal.

[32]  S. Pocock,et al.  Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. , 2016, Journal of the American College of Cardiology.

[33]  G. Mikhail,et al.  Gender differences in coronary heart disease , 2016, Heart.

[34]  J. Spertus,et al.  Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. , 2016, JAMA.

[35]  H. Daida,et al.  Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008. , 2016, Atherosclerosis.

[36]  Harlan M Krumholz,et al.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association , 2016, Circulation.

[37]  Peter L Duffy,et al.  Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. , 2015, Journal of the American College of Cardiology.

[38]  D. Ardissino,et al.  Association of bleeding, mortality and sex in acute coronary syndromes: the missing triangle , 2015, Journal of cardiovascular medicine.

[39]  A. Go,et al.  Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. , 2015, Journal of the American College of Cardiology.

[40]  G. Stone,et al.  Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  H. Miyata,et al.  Gender Differences in In-Hospital Clinical Outcomes after Percutaneous Coronary Interventions: An Insight from a Japanese Multicenter Registry , 2015, PloS one.

[42]  L. Cheskin,et al.  Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. , 2014, JAMA internal medicine.

[43]  J. Mega,et al.  Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI , 2014, Nature Reviews Cardiology.

[44]  H. Miyata,et al.  Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing. , 2014, JACC. Cardiovascular interventions.

[45]  G. Heinze,et al.  Competing risks analyses: objectives and approaches , 2014, European heart journal.

[46]  Y. Jeong.  “East Asian Paradox”: Challenge for the Current Antiplatelet Strategy of “One-Guideline-Fits-All Races” in Acute Coronary Syndrome , 2014, Current Cardiology Reports.

[47]  E. Peterson,et al.  Sex‐Based Differences in Outcomes After Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report From TRANSLATE‐ACS , 2014, Journal of the American Heart Association.

[48]  N. Wenger.  Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines. , 2013, Advances in chronic kidney disease.

[49]  Mandeep Singh,et al.  An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.

[50]  H. Schunkert,et al.  Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. , 2013, American heart journal.

[51]  H. Dauerman,et al.  Women, Bleeding, and Coronary Intervention , 2013, Circulation.

[52]  M. Sabatine,et al.  Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. , 2012, Journal of the American College of Cardiology.

[53]  E. Antman,et al.  Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) , 2011, Circulation.

[54]  Elizabeth R DeLong,et al.  Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.

[55]  Sunil V. Rao,et al.  Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years , 2010, Circulation. Cardiovascular interventions.

[56]  Dick M. Goedhart,et al.  The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial). , 2010, The American journal of cardiology.

[57]  J. Ware,et al.  Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.

[58]  Sunil V. Rao,et al.  Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[59]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[60]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[61]  K. Alexander,et al.  Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.

[62]  L. Newby,et al.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.

[63]  P. Bray,et al.  Platelets of Female Mice Are Intrinsically More Sensitive to Agonists Than Are Platelets of Males , 2004, Arteriosclerosis, thrombosis, and vascular biology.